About Us


A2 Bio Partnerships

A2 Bio Investors Merck logo

A2 Bio has a research collaboration with Merck for its first allogeneic program and an option for a second program. This is Merck’s first partnership in the cell therapy area, and their decision to partner with A2 Bio serves as a validation of the Tmod™ platform. Learn More

A2 Bio Partners Tempus logo

A2 Bio has a diagnostic collaboration with Tempus, a leader in genetic diagnostic testing, artificial intelligence and precision medicine, to develop a companion diagnostic to identify those patients whose tumors have lost HLA-A*02. This diagnostic technology can also be used to support the development of further diagnostic testing for future programs. Learn More

To explore potential partnership opportunities, please contact us at [email protected]